Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Poirot MC"'
Autor:
Silvente-Poirot S; a Cholesterol Metabolism and Therapeutic Innovations, Cancer Research Center of Toulouse , UMR 1037 Inserm-University of Toulouse, Toulouse , France., Segala G; a Cholesterol Metabolism and Therapeutic Innovations, Cancer Research Center of Toulouse , UMR 1037 Inserm-University of Toulouse, Toulouse , France., Poirot MC; a Cholesterol Metabolism and Therapeutic Innovations, Cancer Research Center of Toulouse , UMR 1037 Inserm-University of Toulouse, Toulouse , France., Poirot M; a Cholesterol Metabolism and Therapeutic Innovations, Cancer Research Center of Toulouse , UMR 1037 Inserm-University of Toulouse, Toulouse , France.
Publikováno v:
Autophagy [Autophagy] 2018; Vol. 14 (3), pp. 555-557. Date of Electronic Publication: 2018 Mar 01.
Autor:
Segala G; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France.; Département de Biologie Cellulaire, Université de Genève, Genève, 1211, Switzerland., David M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France.; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., de Medina P; AFFICHEM, Toulouse, F-31400, France., Poirot MC; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Serhan N; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Vergez F; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, F-31100, France., Mougel A; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Saland E; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Carayon K; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Leignadier J; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Caron N; AFFICHEM, Toulouse, F-31400, France., Voisin M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Cherier J; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Ligat L; UMR 1037-CRCT, Pole Technologique, Toulouse, F-31037, France., Lopez F; UMR 1037-CRCT, Pole Technologique, Toulouse, F-31037, France., Noguer E; AFFICHEM, Toulouse, F-31400, France., Rives A; AFFICHEM, Toulouse, F-31400, France., Payré B; Centre de Microscopie Electronique Appliquée à la Biologie, Toulouse, F-31062, France., Saati TA; INSERM-US006 ANEXPLO/CREFRE F-31024, Toulouse, F-31024, France., Lamaziere A; Laboratory of Mass Spectrometry, INSERM ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités-UPMC, CHU Saint-Antoine, Paris, F-75012, France., Despres G; Laboratory of Mass Spectrometry, INSERM ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités-UPMC, CHU Saint-Antoine, Paris, F-75012, France., Lobaccaro JM; Université de Clermont Auvergne, CNRS, INSERM, GReD, Clermont-Ferrand, F-63001, France., Baron S; Université de Clermont Auvergne, CNRS, INSERM, GReD, Clermont-Ferrand, F-63001, France., Demur C; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, F-31100, France., de Toni F; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Larrue C; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Boutzen H; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Thomas F; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Dose Individualisation of Anticancer Drugs Team, Toulouse, F-31037, France., Sarry JE; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Tosolini M; UMR 1037-CRCT, Pole Technologique, Toulouse, F-31037, France., Picard D; Département de Biologie Cellulaire, Université de Genève, Genève, 1211, Switzerland., Record M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Récher C; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France. recher.christian@iuct-oncopole.fr.; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, F-31100, France. recher.christian@iuct-oncopole.fr., Poirot M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France. marc.poirot@inserm.fr., Silvente-Poirot S; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France. sandrine.poirot@inserm.fr.
Publikováno v:
Nature communications [Nat Commun] 2017 Dec 04; Vol. 8 (1), pp. 1903. Date of Electronic Publication: 2017 Dec 04.
Autor:
Galandrin S; Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM, UMR 1048, Université Toulouse, F-31432 Toulouse, France., Onfroy L; Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM, UMR 1048, Université Toulouse, F-31432 Toulouse, France., Poirot MC; Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM, UMR 1048, Université Toulouse, F-31432 Toulouse, France., Sénard JM; Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM, UMR 1048, Université Toulouse, F-31432 Toulouse, France; Service de Pharmacologie Clinique, Faculté de médecine, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse, F-31000 Toulouse, France., Galés C; Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM, UMR 1048, Université Toulouse, F-31432 Toulouse, France. Electronic address: celine.gales@inserm.fr.
Publikováno v:
The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2016 Aug; Vol. 77 (Pt B), pp. 251-63. Date of Electronic Publication: 2016 Apr 21.